A Japan-based biotechnology company developing small-molecule therapeutics targeting protein–protein interactions (PPIs).
Researchers at the Paul Scherrer Institute PSI are the first to have joined two proteins together by means of a free-standing, rigid link. The structural element holds the two protein molecules ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results